Therapy options for chronic lung allograft dysfunction–bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: a systematic review
C Benden, M Haughton, S Leonard… - The Journal of heart and …, 2017 - Elsevier
Background Long-term success of lung transplantation is limited by the development of
chronic lung allograft dysfunction (CLAD), of which bronchiolitis obliterans syndrome (BOS)
is the most common form. This systematic review sought to identify the current evidence
base for CLAD-BOS therapies after initial immunosuppressive treatment strategies. Methods
The MEDLINE, Embase, and Cochrane Library databases from inception to May 3, 2016,
were searched using keywords relating to CLAD-BOS, study designs, and treatments of …
chronic lung allograft dysfunction (CLAD), of which bronchiolitis obliterans syndrome (BOS)
is the most common form. This systematic review sought to identify the current evidence
base for CLAD-BOS therapies after initial immunosuppressive treatment strategies. Methods
The MEDLINE, Embase, and Cochrane Library databases from inception to May 3, 2016,
were searched using keywords relating to CLAD-BOS, study designs, and treatments of …
